Instrument Inactif

Autres langues MASR PHAR

Actions

MPH

PLMSTPH00016

Transformation des aliments

Autres langues

16/08/23	Farmaceutici Procemsa SPA signed an agreement to acquire an unknown majority stake in Master Pharm SA.
24/06/23	Master Pharm SA's Equity Buyback announced on June 24, 2020, has expired.
21/09/22	Master Pharm SA Reports Earnings Results for the Half Year Ended June 30, 2022
14/09/22	Master Pharm SA announces an Equity Buyback for 2,600,000 shares, for PLN 15.86 million.
14/09/22	Master Pharm SA authorizes a Buyback Plan.
13/05/22	Master Pharm SA Reports Earnings Results for the First Quarter Ended March 31, 2022
26/04/22	Master Pharm SA Reports Earnings Results for the Full Year Ended December 31, 2021
19/11/21	Master Pharm SA Reports Earnings Results for the Nine Months Ended September 30, 2021
13/10/21	Master Pharm SA's Equity Buyback announced on October 4, 2021, has expired.
04/10/21	Master Pharm SA announces an Equity Buyback for 1,000,000 shares, for PLN 4.5 million.
04/10/21	Master Pharm SA authorizes a Buyback Plan.
30/09/21	Master Pharm Sa Reports Earnings Results for the Half Year Ended June 30, 2021
17/05/21	Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.
17/05/21	Master Pharm SA Reports Earnings Results for the First Quarter Ended March 31, 2021
15/04/21	Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.
15/04/21	Master Pharm Sa Reports Earnings Results for the Full Year Ended December 31, 2020
19/11/20	Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.
19/11/20	Master Pharm Sa Announces Earnings Results for the Nine Months Ended September 30, 2020
24/09/20	Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.
24/09/20	Master Pharm Sa Reports Earnings Results for the Half Year Ended June 30, 2020
24/06/20	Master Pharm SA announces an Equity Buyback for 4,300,000 shares, for PLN 18.2 million.
24/12/19	An unknown natural person acquired AvetPharma Sp. z o.o. from Master Pharm SA for PLN 1000.
09/04/18	Master Pharm Mulls Potential Acquisitions
21/12/17	Master Pharm SA Withdraws Talks To Acquire Business Of Company Operating In Pharma
27/04/17	Certain Series A Common Shares of Master Pharm SA are subject to a Lock-Up Agreement Ending on 27-APR-2017.